nach oben

Erschienen in:

01.04.2005 | Hepatobiliary-Pancreas

Liver haemangiomas undetermined at grey-scale ultrasound: contrast-enhancement patterns with SonoVue and pulse-inversion US

verfasst von: Tommaso Vincenzo Bartolotta, Massimo Midiri, Emilio Quaia, Michele Bertolotto, Massimo Galia, Filippo Cademartiri, Roberto Lagalla

Erschienen in: European Radiology | Ausgabe 4/2005

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study was to describe the spectrum of contrast-enhancement patterns of hepatic haemangiomas undetermined at grey-scale ultrasound (US) on SonoVue-enhanced pulse-inversion (PI) US. Twenty patients (11 women, nine men) with 35 haemangiomas (size range: 1–7 cm; mean: 3.1 cm) undetermined at baseline US underwent PI at low M.I. (0.05–0.08) after i.v. injection of SonoVue. All haemangiomas were confirmed by typical helical computed tomography (CT) and/or magnetic resonance imaging (MRI) findings. US examinations were videotaped and then reviewed by two experienced radiologists blinded to the final diagnosis. Readers evaluated by consensus the baseline echogenicity and the dynamic enhancement pattern of each lesion, in comparison with adjacent liver parenchyma. After administration of SonoVue, 31/35 (88%) haemangiomas showed peripheral hyperechoic nodules in the arterial phase, followed by progressive centripetal fill-in, which was complete in 25/35 cases and incomplete in 6/35 cases. Three out of 35 (9%) haemangiomas showed rapid and complete fill-in in the arterial phase, which persisted in the portal and delayed phases. Finally, 1/35 haemangiomas (3%) showed a rim of arterial contrast enhancement with progressive and complete centripetal fill-in in portal-venous and delayed phases. In conclusion, PI after the administration of SonoVue enabled the depiction of typical contrast-enhancement patterns in haemangiomas undetermined at baseline US.

Mergo PJ, Ros PR (1998) Benign lesions of the liver. Radiol Clin North Am 36:319–331PubMed

Moody AR, Wilson SR (1993) Atypical hepatic hemangioma: a suggestive sonographic morphology. Radiology 188:413–417

Harvey CJ, Albrecht T (2001) Ultrasound of focal liver lesions. Eur Radiol 11:1578–1593

Vilgrain V, Boulous L, Vullierme MP et al (2000) Imaging of atypical hemangiomas of the liver with pathological correlation. Radiographics 20:379–397PubMed

Hosten N, Puls R, Bechstein WO, Felix R (1999) Focal liver lesions: Doppler ultrasound. Eur Radiol 9:428–435CrossRef

Perkins AB, Imam K, Smith WJ, Cronan JJ (2000) Color and power Doppler sonography of liver hemangiomas: a dream unfulfilled? J Clin Ultrasound. 28:159–165CrossRef

Kim TK, Han JK, Kim AY et al (1999) Hepatic hemangiomas using a sonographic contrast agent (Levovist) and Power Doppler ultrasonography. J Ultrasound Med 18:737–743PubMed

Burns PN, Wilson SR, Simpson DH (2000) Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol 35:58–71

Bertolotto M, Dalla Palma L, Quaia E et al (2000) Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results. Eur Radiol 10:1369–1376CrossRefPubMed

10.

Quaia E, Bertolotto M, Dalla Palma L (2002) Characterization of liver hemangiomas with pulse inversion harmonic imaging. Eur Radiol 12:537–544PubMed

11.

Bartolotta TV, Midiri M, Galia M et al (2003) Atypical liver hemangiomas: contrast-enhancement patterns with SH U 508A and pulse-inversion US. Radiol Med 106:320–328

12.

Schneider M, Arditi M, Barrau M et al (1995) BRI: a new ultrasonographic contrast agent based on sulphur hexafluoride-filled microbubbes. Invest Radiol 30:451–457

13.

Quaia E, Degobbis F, Tona G et al (2004) Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue. Radiol Med 107:155–165

14.

Nicolau C, Catala V, Vilana R, Gilabert et al (2004) Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 14:1092–1099CrossRefPubMed

15.

Hanafusa K, Ohashi I, Himeno Y et al (1995) Hepatic hemangioma: findings with two phase CT. Radiology 196:465–469PubMed

16.

Semelka RC, Brown ED, Ascher SM et al (1994) Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology 192:401–406PubMed

17.

Nino-Murcia M, Olcott EW, Jeffrey RB et al (2000) Focal liver lesions: pattern-based classification scheme for enhancement at arterial phase. Radiology 215:746–751PubMed

18.

Leen E, Angerson WJ, Yarmenitis S et al (2002) Multi-centre clinical study evaluating the efficacy of SonoVue (BR1), a new contrast agent in Doppler investigation of focal hepatic lesions. Eur J Radiol 41:200–206CrossRef

19.

Bartolotta TV, Midiri M, Scialpi M, Sciarrino E, Galia M, Lagalla R (2004) Focal nodular hyperplasia in normal and fatty liver: a qualitative and quantitative evaluation with contrast-enhanced ultrasound. Eur Radiol 14:583–591CrossRefPubMed

20.

Foley D, Jochem RJ (1991) Computed tomography. Focal and diffuse liver disease. Radiol Clin North Am 29:1213–1222

21.

Ros PR (2000) Benign liver lesions. Eur Radiol 10 (Suppl 2):S175–S184CrossRef

22.

Farrell MA, Charboneau JW, Reading CC (2000) Sonographic–pathologic correlation of the hyperechoic border of an atypical hepatic hemangioma. J Ultrasound Med 20:169–170

23.

Brancatelli G, Federle MP, Blachar A et al (2001) Hemangioma in the cirrhotic liver: diagnosis and natural history. Radiology 219:69–74

24.

Caturelli E, Pompili M, Bartolucci F et al (2001) Hemangioma-like lesions in chronic liver disease: diagnostic evaluation in patients. Radiology 220:337–342

25.

Bollinger A, Putti P, Barras JP et al (1974) Red blood cell velocity in nailfold capillaries of men, measured by a television microscopy technique. Microvasc Res 7:61–72CrossRef

26.

Young LK, Yang WT, Chan KW et al (1998) Hepatic hemangiomas: quantitative color power US angiography—facts and fallacies. Radiology 207:51–57

27.

Strobel D, Krodel U, Martus P et al (2000) Clinical evaluation of contrast-enhanced color Doppler sonography in the differential diagnosis of liver tumors. J Clin Ultrasound 28:1–13CrossRefPubMed

28.

Dill-Macky MJ, Burns PN, Khalili K et al (2002) Focal hepatic masses: enhancement patterns with SH U 508 A and pulse-inversion US. Radiology 222:95–102PubMed

29.

Wilson SR, Burns PN, Muradali D et al (2000) Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. Radiology 215:153–161

30.

Kim TK, Choi BI, Han JK et al (2000) Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology 216:411–417PubMed

31.

Tanaka S, Ioka T, Oshikawa O et al (2001) Dynamic sonography of hepatic tumors. Am J Roentgenol 177:799–805

32.

Von Herbay A, Vogt C, Haussinger D (2002) Pulse Inversion sonography in the early phase of the sonographic contrast agent Levovist: differentiation between benign and malignant focal liver lesions. J Ultrasound Med 21:1191–2000PubMed

33.

Sidhu PS, Shaw AS, Ellis SM et al (2004) Microbubble ultrasound contrast in the assessment of hepatic artery patency following liver transplantation: role in reducing frequency of hepatic artery arteriography. Eur Radiol 14:21–30CrossRefPubMed

34.

Klein D, Jenett M, Gassel HJ et al (2004) Quantitative dynamic contrast-enhanced sonography of hepatic tumors. Eur Radiol 14:1082–1091CrossRefPubMed

35.

Horton KM, Bluemke DA, Hruban RH et al (1999) CT and MR imaging of benign hepatic and biliary tumors. Radiographics 19:431–451PubMed

36.

Correas JM, Bridal L, Lesavre A et al (2001) Ultrasound contrast agent: properties, principles of action, tolerance, and artifacts Eur Radiol 11:1316–1328CrossRefPubMed

37.

Dalla Palma L, Bertolotto M (1999) Introduction to ultrasound contrast agents: physics overview. Eur Radiol 9(Suppl 3):S338–S342CrossRef

38.

Madjar H, Prömpeler HJ, Del Favero C et al (2000) A new Doppler signal enhancing agent for flow assessment in breast lesions. Eur J Ultrasound 12:123–130

39.

M Schneider (1999) SonoVue, a new ultrasound contrast agent. Eur Radiol 9 (Suppl 3):S347–S348CrossRef

40.

Lencioni R, Cioni D, Bartolozzi C (2002) Tissue harmonic and contrast agent and contrast-specific imaging: back to gray scale in ultrasound. Eur Radiol 12:151–165PubMed

41.

Leen E (2001) The role of contrast-enhanced ultrasound in the characterisation of focal liver lesions. Eur Radiol 11:27–34

42.

Nicolau C, Catala V, Bru C (2003) Characterization of focal liver lesions with contrast-enhanced ultrasound. Eur Radiol 13 (Suppl 3):N70–N78

43.

Albrecht T, Oldenburg A, Hohmann J et al (2003) Imaging of liver metastases with contrast-specific low-MI real-time ultrasound and SonoVue. Eur Radiol 13 (Suppl 3):N79–N86

44.

Quaia E, Bertolotto M, Forgacs B et al (2003) Detection of liver metastases by pulse inversion harmonic imaging during Levovist late phase: comparison with conventional ultrasound and helical CT in 160 patients. Eur Radiol. 13:475–483PubMed

45.

Tranquart F, Correas JM, Martegani A et al (2004) Feasibility of real time contrast enhanced ultrasound in renal disease. J Radiol 85:31–36

46.

Bartolotta TV, Midiri M, Galia M et al (2001) Benign hepatic tumors: MRI features before and after superparamagnetic iron oxide administration. Radiol Med 101:219–229

47.

Kim S, Chung JJ, Kim MJ et al (2000) Atypical inside-out pattern of hepatic hemangiomas. Am J Roentgenol 174:1571–1574

48.

Konno K, Ishida H, Sato M et al (2001) Liver tumors in fatty liver: difficulty in ultrasonographic interpretation. Abdom Imaging 26:487–491CrossRef

Titel: Liver haemangiomas undetermined at grey-scale ultrasound: contrast-enhancement patterns with SonoVue and pulse-inversion US
verfasst von: Tommaso Vincenzo Bartolotta
Massimo Midiri
Emilio Quaia
Michele Bertolotto
Massimo Galia
Filippo Cademartiri
Roberto Lagalla
Publikationsdatum: 01.04.2005
Verlag: Springer-Verlag
Erschienen in: European Radiology / Ausgabe 4/2005
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-004-2569-9

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Liver haemangiomas undetermined at grey-scale ultrasound: contrast-enhancement patterns with SonoVue and pulse-inversion US

Abstract

Neu im Fachgebiet Radiologie

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Klinikreform soll zehntausende Menschenleben retten

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Update Radiologie

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2005

Dynamic echo-planar MR imaging of the diaphragm for a 3D dynamic analysis

Assessment of coronary artery stents using 16-slice MDCT angiography: evaluation of a dedicated reconstruction kernel and a noise reduction filter

Nuclear imaging of an extraskeletal retroperitoneal osteosarcoma: respective contribution of 18FDG-PET and 99mTc oxidronate (2005:1b)

Robot-assisted biopsy using ultrasound guidance: initial results from in vitro tests

Comparison of multislice CT arthrography and MR arthrography for the detection of articular cartilage lesions of the elbow

In which patients should serum creatinine be measured before iodinated contrast medium administration?

Neu im Fachgebiet Radiologie

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Klinikreform soll zehntausende Menschenleben retten

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Update Radiologie